Voya Investment Management LLC Rubius Therapeutics, Inc. Transaction History

Voya Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $14,295 - $108,208	-18,095 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $2,778 - $5,091	287 Added 1.61%	18,095 $175,000
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $48,615 - $62,091	2,184 Added 13.98%	17,808 $435,000
Q1 2021 May 17, 2021	BUY	$8.02 - $32.01 $2,526 - $10,083	315 Added 2.06%	15,624 $414,000
Q4 2020 Feb 16, 2021	BUY	$4.23 - $8.73 $9,069 - $18,717	2,144 Added 16.29%	15,309 $116,000
Q2 2020 Aug 14, 2020	SELL	$4.01 - $6.88 $16,220 - $27,829	-4,045 Reduced 23.5%	13,165 $79,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $20,251 - $39,550	2,801 Added 19.44%	17,210 $163,000
Q2 2019 Aug 14, 2019	BUY	$13.5 - $19.94 $12,312 - $18,185	912 Added 6.76%	14,409 $227,000
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $179,105 - $249,829	13,497 New	13,497 $244,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.